PGC‐1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Muscle and Nerve

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mus.22217PMID 22102466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics

  2011cited by this paper
• Spinal Cord mRNA Profile in Patients with ALS: Comparison with Transgenic Mice Expressing the Human SOD-1 Mutant

  2009cited by this paper
• Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity.

  2009cited by this paper
• Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

  2009cited by this paper
• MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models

  2008cited by this paper
• Skeletal muscle is a primary target of SOD1G93A-mediated toxicity.

  2008cited by this paper
• Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis

  2008cited by this paper
• The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

  2007cited by this paper
• PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy

  2007cited by this paper
• PGC‐1α‐Induced Mitochondrial Alterations in 3T3 Fibroblast Cells

  2007cited by this paper
• PGC-1alpha-induced mitochondrial alterations in 3T3 fibroblast cells.

  2007cited by this paper
• PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy.

  2007cited by this paper
• Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.

  2006cited by this paper
• Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis

  2006cited by this paper
• Calorie restriction mimetics: an emerging research field

  2006cited by this paper
• Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

  2006cited by this paper
• Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

  2006cited by this paper
• Transcriptional Repression of PGC-1a by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

  2006cited by this paper
• Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha.

  2005cited by this paper
• PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells.

  2005cited by this paper
• PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells

  2005cited by this paper
• Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice.

  2004cited by this paper
• Effect of caloric restriction on mitochondrial reactive oxygen species production and bioenergetics: reversal by insulin.

  2004cited by this paper
• Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

  2004cited by this paper
• Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1 Null Mice

  2004cited by this paper
• Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS.

  2004cited by this paper
• Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

  2003cited by this paper
• Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells.

  2003cited by this paper
• Assessing disease onset and progression in the SOD1 mouse model of ALS

  2003cited by this paper
• Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells*

  2003cited by this paper
• Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis

  2002cited by this paper
• Influence of aging and long-term caloric restriction on oxygen radical generation and oxidative DNA damage in rat liver mitochondria.

  2002cited by this paper
• Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.

  2002cited by this paper
• Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients

  2002cited by this paper
• Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders.

  2002cited by this paper
• Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders

  2002cited by this paper
• Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice*

  2002cited by this paper
• The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse.

  2001cited by this paper
• Semiquantitative measurement of acetylcholine receptor at the motor end-plate in myasthenia gravis.

  2001cited by this paper
• Effects of myocardial ischemia and reperfusion on mitochondrial function and susceptibility to oxidative stress

  2001cited by this paper
• Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart

  2001cited by this paper
• Mitochondrial Participation in Ischemic and Traumatic Neural Cell Death

  2000cited by this paper
• Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis.

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

  2000cited by this paper
• Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis

  2000cited by this paper
• Generation of superoxide in cardiomyocytes during ischemia before reperfusion.

  1999cited by this paper
• Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.

  1999cited by this paper
• Selective loss of alpha motoneurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis.

  1998cited by this paper
• Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis.

  1998cited by this paper
• Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1

  1998cited by this paper
• Selective Loss of α Motoneurons Innervating the Medial Gastrocnemius Muscle in a Mouse Model of Amyotrophic Lateral Sclerosis

  1998cited by this paper
• Transgenic animal models of familial amyotrophic lateral sclerosis

  1997cited by this paper
• An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

  1995cited by this paper
• Acetylcholine receptor gene expression at the developing neuromuscular junction.

  1995cited by this paper
• Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration

  1994cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis.

  1994cited by this paper
• Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse.

  1994cited by this paper
• Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Plasma amino acid levels in patients with amyotrophic lateral sclerosis.

  1992cited by this paper
• Role of electromyography in amyotrophic lateral sclerosis

  1991cited by this paper
• Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

  1990cited by this paper
• Abnormal glutamate metabolism in amyotrophic lateral sclerosis

  1987cited by this paper
• Differential regulation of muscle acetylcholine receptor gamma- and epsilon-subunit mRNAs.

  1987cited by this paper
• Differential regulation of muscle acetylcholine receptor γ‐and ϵ‐subunit mRNAs

  1987cited by this paper

• The Interplay Between Nurr1 and Mitochondrial Biogenesis: Implications for Neurodegenerative Therapy

  2026cites this paper
• aEffect of chlorides on the deterioration of mechanical properties and microstructural evolution of cement-based materials subjected to sulphate attack

  2025cites this paper
• Neuronal Activity-Dependent Gene Dysregulation in C9orf72 i3Neuronal Models of ALS/FTD Pathogenesis.

  2025cites this paper
• Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential

  2025cites this paper
• Neuronal Activity-Dependent Gene Dysregulation in C9orf72 i3Neuronal Models of ALS/FTD Pathogenesis

  2025cites this paper
• A 6-Minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models

  2024cites this paper
• A 6-minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models

  2024cites this paper
• Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis

  2023cites this paper
• Mitochondrial regulation of local supply of energy in neurons

  2023cites this paper
• Protective effects of EVs/exosomes derived from permanently growing human MSC on primary murine ALS motor neurons.

  2023cites this paper
• Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Antioxidant-based neuroprotective effect of dimethylsulfoxide against induced traumatic brain injury in a rats model

  2022cites this paper
• Effect of resistance and power training with walking in different directions on the serum concentrations of P3NP and CAF, the lower body muscle strength and motor function in elderly men

  2022cites this paper
• Mitochondria and Neurodegenerative Diseases

  2021cites this paper
• Covering the Role of PGC-1α in the Nervous System

  2021cites this paper
• TBN improves motor function and prolongs survival in a TDP-43M337V mouse model of ALS.

  2021cites this paper
• Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases

  2021cites this paper
• Mitochondrial abnormalities in neurological disorders

  2021cites this paper
• Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model

  2020cites this paper
• The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis.

  2020cites this paper
• Overexpression of NDRG2 in skeletal muscle does not ameliorate the effects of stress in vivo

  2020cites this paper
• Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics

  2020cites this paper
• Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice.

  2020cites this paper
• Astrocytes in Motor Neuron Diseases.

  2019cites this paper
• Protective effects of the caffeine against neurodegenerative diseases.

  2019cites this paper
• Ludolph Metabolism in Presymptomatic Mutation Carriers of familial Amyotrophic Lateral Sclerosis

  2019cites this paper
• Research Progress in Signaling Pathways That Regulate Life Span

  2019cites this paper
• Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity

  2019cites this paper
• PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.

  2018cites this paper
• Thermoregulation in amyotrophic lateral sclerosis.

  2018cites this paper
• ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.

  2017cites this paper
• A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice

  2017cites this paper
• The Bioenergetic Engine : Muscle Metabolic Properties and Hypermetabolism in ALS

  2017cites this paper
• What is “Hyper” in the ALS Hypermetabolism?

  2017cites this paper
• Investigating postzygotic de novo mutations and somatic mosaicism in monozygotic twins discordant for complex disorders

  2017cites this paper
• Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway?

  2017cites this paper
• AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.

  2016cites this paper
• Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.

  2016cites this paper
• Lentivirus-mediated PGC-1α overexpression protects against traumatic spinal cord injury in rats.

  2016cites this paper
• Linkage of Stress with Neuromuscular Disorders.

  2016cites this paper
• The role of ALS associated genes and c-Jun in neurodegeneration

  2016cites this paper
• Melatonin and Other Neuroprotective Agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis

  2016cites this paper
• Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Gly482Ser PGC-1α Gene Polymorphism and Exercise-Related Oxidative Stress in Amyotrophic Lateral Sclerosis Patients

  2016influential citation
• Neuroprotective agents target molecular mechanisms of disease in ALS.

  2015cites this paper
• Mutual exacerbation of PGC-1α deregulation and α-synuclein oligomerization

  2015cites this paper
• Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders.

  2015cites this paper
• Signalling Through the PGC-1alpha Pathway Mediates an Inducible Stress Response in Retinal Astrocytes to Resist Oxidative and Metabolic Insults

  2015cites this paper
• Mitochondrial Dysfunction in Stem Cell Aging

  2015cites this paper
• Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral Sclerosis.

  2015cites this paper
• A study of mitochondrial biogenesis in the rodent nervous system

  2015cites this paper
• Modulations du métabolisme et de l’autophagie induites par l’exercice physique dans un modèle souris de sclérose latérale amyotrophique (SLA)

  2015cites this paper
• Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death.

  2015cites this paper
• The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle

  2014cites this paper
• Amyotrophic Lateral Sclerosis: A Glial Perspective

  2014cites this paper
• Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes.

  2014influential citation
• The role of Ppargc1álpha in neuronal survival and myelination in the neocortex

  2014influential citation
• Turn up the power – pharmacological activation of mitochondrial biogenesis in mouse models

  2014influential citation
• Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS).

  2014cites this paper
• Cerebellar transcriptional alterations with Purkinje cell dysfunction and loss in mice lacking PGC-1α

  2014cites this paper
• Mutual exacerbation of peroxisome proliferator‐activated receptor γ coactivator 1α deregulation and α‐synuclein oligomerization

  2014cites this paper
• Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model

  2014cites this paper
• PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis.

  2013cites this paper
• Histone deacetylases and their role in motor neuron degeneration

  2013cites this paper
• Combining biological and electrical stimulation therapies following spinal cord injury

  2013cites this paper
• Lipoic acid restores age‐associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1α transcriptional pathway

  2013cites this paper
• Ernährung und Metabolismus wichtig für die Prognose

  2013cites this paper
• Therapeutic neuroprotective agents for amyotrophic lateral sclerosis

  2013cites this paper
• Using genetically modified stem cells to halt the progression of ALS

  2013cites this paper
• Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology

  2013cites this paper
• The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis

  2012cites this paper
• PGC1&agr; and mitochondrial metabolism – emerging concepts and relevance in ageing and neurodegenerative disorders

  2012cites this paper
• Pgc-1α Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased Bdnf

  2012cites this paper
• 2 Running title : Mitochondria in neurodegeneration

  2012influential citation
• Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function

  2012cites this paper
• A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset.

  2012cites this paper
• Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.

  2012cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases

  2012influential citation
• Transcriptional regulators and neurotrophic factors in the pathogenesis of Amyotrophic Lateral Sclerosis ( ALS ) Histopathological and biochemical studies in the G 93 A ALS mouse model and in ALS post mortem tissue

  2012cites this paper
• Muscling in on PGC-1α for improved quality of life in ALS.

  2012cites this paper
• Extranuclear localization of SIRT1 and PGC-1α: an insight into possible roles in diseases associated with mitochondrial dysfunction.

  2012cites this paper
• Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice

  2012cites this paper
• Molecular Signatures of Amyotrophic Lateral Sclerosis Disease Progression in Hind and Forelimb Muscles of an SOD1G93A Mouse Model

  2012cites this paper
• Peroxisome proliferator‐activated receptor‐γ cofactors in neurodegeneration

  2012cites this paper
• PGC-1α: a master gene that is hard to master

  2012cites this paper
• Characterization of the Role of Mitochondrial Function During Tumor Development and Muscle Wasting

  2012cites this paper